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Abstract
Myotonic dystrophy (DM), the most prevalent muscular 
disorder in adults, is caused by (CTG)n-repeat expansion in 
a gene encoding a protein kinase (DM protein kinase; 
DMPK) and involves changes in cytoarchitecture and ion 
homeostasis. To obtain clues to the normal biological role of 
DMPK in cellular ion homeostasis, we have compared the 
resting [Ca2+](J the amplitude and shape of depolarization- 
induced Ca2+ transients, and the content of ATP-driven ion 
pumps in cultured skeletal muscle cells of wild-type and 
DMPK[—/- ]  knockout mice.
In vitro-differentiated DMPK[—/ ~ ] myotubes exhibit a 
higher resting [Ca2*]j than do wild-type myotubes because 
of an altered open probability of voltage-dependent L-type 
Ca2‘ and Na+ channels. The mutant myotubes exhibit 
smaller and slower Ca2 ‘ responses upon triggering by ace­
tylcholine or high external K+. In addition, we observed 
that these Ca2+ transients partially result from an influx of 
extracellular Ca2+ through the L-type Ca2+ channel. Neither 
the content nor the activity of Na+/K+ ATPase and sarco­
plasmic reticulum Ca2+-ATPase are affected by DMPK ab­
sence.
In conclusion, our data suggest that DMPK is involved in 
modulating the initial events of excitation-contraction cou­
pling in skeletal muscle. (J. Clin. Invest 1997- 100:1440- 
1447.) Key words: excitation-contraction coupling * ion 
channels • ion pumps • knockout mouse • cultured myo­
tubes
Introduction
Myotonic dystrophy (DM)1 follows an autosomal dominant in­
heritance, and is characterized by a wide variety of symptoms, 
including increased excitability and delayed relaxation of mus­
cle, muscle weakness and wasting, ocular cataract, sensorineu-
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ral deafness, cardiac conduction defects, hypersomnia, testicu­
lar atrophy causing male sterility, and endocrine dysfunction 
(1). Clinical manifestation of this rather frequent disorder is 
caused by expansion of an unstable CTG-repeat in the 3'- 
untranslated region of a gene encoding the myotonic dystrophy 
protein kinase (DMPK), with the age of onset and the severity 
of the disease being correlated to the extent of expansion (2-4).
Contradictory results have been obtained with regard to 
the effects of abnormally long CTG repeats on DMPK mRNA 
and protein levels in patient tissues (5-8). In addition, the 
study of transgenic mouse models with altered DMPK levels 
(9, 10) has not provided the answer on the question whether 
over- or underexpression of this protein is involved in disease 
etiology. Homozygous D M PK [-/-] mice exhibit only minor 
changes in neck muscle fibres at older age, whereas animals 
carrying multiple copies of the DMPK transgene show hyper­
trophic cardiomyopathy and enhanced neonatal mortality as 
the only features.
Typically, muscle fibers and/or cultured skeletal muscle 
cells of DM patients exhibit a decreased resting membrane po­
tential (11-13) and increased basal cytosolic Na+ and Ca2+ 
concentrations (14-16). These features may be attributed to 
anomalies in the functioning of voltage-operated Na+ channels 
(17,18) and Ca2+ channels (15,16) and/or to a reduced content 
of Na+/K+~ATPase and sarcoplasmic reticulum (SR) Ca2+- 
ATPase (19, 20). In addition, the persistence of an apamin- 
receptor, i.e. Ca2+-activated K* channel, has been demon­
strated (21).
Many of these ion channels and ion pumps are key players 
in the excitation-contraction (E-C) coupling mechanism of 
skeletal muscle in vivo, a cascade of events in which, sequen­
tially, acetylcholine receptors (AChR) of the neuromuscular 
junction, sarcolemmal tetrodotoxin-sensitive voltage-oper­
ated Na+ channels (TTXR), T-tubular dihydropyridine recep­
tors (DHPR), and finally ryanodine receptors (RyR), i.e. Ca2i‘ 
release channels in the terminal cisternae of the SR, are in­
volved (22). E-C coupling of vertebrate skeletal muscle is 
thought to occur by a mechanical coupling, in which intramem­
brane charge movements and associated conformational 
changes of the voltage-sensing DHPR activate the RyR with­
out entry of external Ca2+ through DHPR (23-25). Before re­
laxation, the disturbed ion concentrations are restored to rest­
ing levels by ATP-driven ion pumps, i.e., Na+/K+-ATPase and 
SR Ca2+-ATPase.
This whole process is subject to complex regulation in 
which local luminal and cytosolic Ca2+ and ATP levels are in-
1. Abbreviations used in this paper: ACh(R), acetylcholine (receptor); 
D H PR, dihydropyridine receptor; DM, myotonic dystrophy; DMPK, 
myotonic dystrophy protein kinase; E-C, excitation-contraction; 
RyR, ryanodine receptor; SR, sarcoplasmic reticulum; TTX(R), 
tetrodotoxin (receptor); T d, half-clecay time; half-increase time; 
3-0-M FPase, 3-0-methylfluorescein phosphatase.
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volved. It is also influenced by protein phosphorylation and 
ion channel-modulating proteins like FK506, triadin, or calse- 
questrin. Since dysregulation of ion fluxes is a likely determin­
ing factor in the abnormal cellular functions in DM, and since 
DMPK-mediated protein phosphorylation could play a role, 
we examined if and how DMPK deficiency affects the depolar­
ization behavior and Ca2+ homeostasis in cultured skeletal 
muscle ceils in the absence or presence of specific inhibitors of 
the voltage-operated ion channels or the SR Ca2'1' release 
channel. We also determined the activity and content of SR 
Ca24*-ATPase and Na+/K+-ATPase in cultured muscle cells 
and skeletal muscle of wild-type and DMPK[—/-] mice. Al­
though the morphological and physiological effects of DMPK 
absence at the animal level are surprisingly mild, we demon­
strate here, that DMPK deficiency has conspicuous conse­
quences at the cellular level. Our finding of abnormally operat­
ing TTXRs and DHPRs gives evidence for a relation between 
DMPK activity and ion homeostasis in skeletal muscle.
Methods
Materials, The acetoxymethyl ester of Fura-2 (Fura-2/AM) was pur­
chased from Molecular Probes Europe (Leiden, The Netherlands); 
acetylcholine chloride (ACh), tetrodotoxin (TTX), ryanodine and 
ionomycin were from Sigma (St. Louis, MO, USA); and nifedipine 
from Bayer (Leverkusen, Germany). Sources of other materials were 
described previously (20,26).
DMPK-deficient mice. Homozygous DMPK-deficient (DMPK[~7—]) 
mice were generated by targeted mutagenesis and genotyped by PCR 
analysis as described (9). D M P K [ - / - ]  animals from the F3 genera­
tion (on a mixed C57BL/6 X 129/OLA 50-50% background) were 
used. Wild-type animals from the C57BL/6 inbred strain, and from a 
colony with a C57BL/6 X 129/OLA mixed background were taken as 
controls.
Cytosolic Ca2+ concentration measurement in cultured skeletal 
muscle cells. Hind leg muscles of 3-10-d-old wild-type and D M P K [- /- ]  
mice were dissociated, and the isolated satellite cells were allowed to 
proliferate for 2 d, and were then cultured under differentiation-pro­
moting conditions for 4 d on collagen-coated glass coverslips (i|) 25 
mm) in serum-containing media, as described for human muscle cells 
(26). The free cytosolic Ca2+ concentration ([Ca2+]j) and the effects of 
depolarization induced by the addition of 20 fiM ACh or 125 mM 
KC1 on [Ca2+]i were measured in single cells with Fura-2 using con­
ventional fluorescence video microscopy (26), For calibration, Ca2+- 
saturaled or Ca2+-free dye was set by 2 (jlM ionomycin in the presence 
o f  1.8 mM Ca2+ (pH 7.5) or 20 mM EGTA (pH 8.0), respectively. U n­
der these conditions the myotubes remain attached to the coverslip. 
Although the calibration parameters of wild-type and D M P K [- /—] 
skeletal muscle cells did not differ significantly, we used these pa­
rameters strictly separated for calculation of [Ca2'h]j to rule out cell- 
type-dependent artefacts (27). The half-increase (tj) and half-decay 
time (Td) of the depolarization-triggered Ca2+ responses were ana­
lyzed as described (26,28).
SR Ca2*-ATPcise and Na+/K*-ATPase. The activity and concen­
tration of SR Ca2+-ATPase were examined in homogenates of cul­
tured muscle cells (differentiated for 4 d) and hind leg skeletal muscle 
of adult mice by measuring Ca2+-dependent ATP hydrolysis and 
steady-state phosphorylation, respectively (20). The activity of 
N a+/K +-ATPase was assayed as the K+-dependent, ouabain-sensitive 
3-O-methylfluorescein phosphatase (3-0-MFPase) activity and the 
content of N a+/K +-ATPase was derived from the binding capacity of 
[3H]ouabain (20).
Other procedures. Creatine kinase (CK) activity of cultured mus­
cle cells (differentiated for 4 d) was determined with the CK N-ace- 
tylcysteine-activated monotest (26). For determining the percentage 
CK muscle-specific isoenzyme MM (CK-MM), this isoenzyme was
separated from the other CK isoenzymes by gel electrophoresis (29). 
The protein content was assayed according to Lowry et al. (30) with 
BSA as a standard.
Statistics. Data represent means ±SD. Statistical analysis was per­
formed by means of the unpaired Student’s t test, and significance 
was set at P < 0.05.
Results
4
General characteristics of cultured wild-type and DMPK[—/~~] 
skeletal muscle cells. Upon differentiation, in vitro skeletal 
muscle cells derived from wild-type and DMPK-deficient mice 
exhibit a similar morphological appearance. Typically, the di­
ameter of these cells is ^  10-20 fim, whereas their length var­
ies between 500 and 700 jxm. Also, the total CK activity of 
wild-type (1.93±0.59 U/mg protein; n = 11) and mutant cells 
(1.84±0.84 U/mg protein; n ~ 5) and the percentage of CK- 
MM, a measure for the overall maturation grade, are the 
same for both cell types (wild-type: 33.8± 10.1; n = 11, and 
DMPK[—/ —]: 37.1 ±5,8; n = 5), Spontaneous contractions of 
wild-type and DMPK[—/—] myotubes are occasionally observed 
in culture, and occurred frequently upon agonist-induced de­
polarization in both cell types.
Ca2* homeostasis of wild-type skeletal muscle cells. The rest­
ing [Ca2+]i of differentiated wild-type mouse skeletal muscle 
cells in culture is 120 n M  (Table I), Depolarization of the sar- 
colemma of these cells either by 20 (jlM ACh or by 125 m M  
KC1, induces Ca2+ transients with an amplitude ([Ca2+]iimax) of 
~  0.8 |xM (Fig. 1) and a t\ and Td of ^  3 and 5 s, respectively. 
The provoked Ca2+ responses are completely prevented by in­
hibition of the SR Ca2+ release channel (RyR) using 10 pM ry­
anodine (Fig. 2, B and C). Thus, Ca2+ release from the SR is 
entirely responsible for the increase of the [Ca21 ]{, indicating 
that the wild-type myotubes possess a skeletal muscle type of 
E-C coupling mechanism (28, 31). As anticipated, also ni­
fedipine (5 fxM), a blocker of DHPR, impedes the depolariza­
tion-induced Ca2+ transients (Fig. 3, B and C). Inhibition of 
TTXR by 5 \ jM  tetrodotoxin only partially suppresses depo­
larization by ACh (Fig. 4 B). This inhibition is incomplete due 
to the coexistence of TTX-sensitive and TTX-resistant volt-
Table 1. Ca2* Transients Induced by ACh or KCl in Cultured 
Skeletal Muscle Cells From Wild-type and DM PK[-/-] Mice
Stim ulus Param eter Witcl-Lype DMPK[-y~l
None [Ca2 Jj.basal 122±17 185 ±24:l=
(170) (63)
20 ¡lM  ACh [Ca2'l‘]iiIIU}X 775±13l 511 + 124*
Ti 3.0±0.6 6.6 ±1.9*
Td 4.6±0.8 8.4 ±2.1*
(84) (38)
125 m M  KCI [Ca2"]i>m!ix 881 ±164 552±130*
Tj 3.2±0.7 6.1 ±1.7*»
Td 4.8±0,7 7.9±2.8*
(86) (25)
Values are means±SD of the number of muscle cells examined (listed 
between parentheses) from at least four individual cultures. The valves 
of [Ca2+]j are expressed in nM, and the half-increase (t|) or half-decay 
time (Td) in s. Parameters of DM PK[~/~] and wild-type cells differ with 
*/><0.01.
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Figure /. Depolarization-induced Ca2+ transients m cultured skeletal muscle cells derived from wild-type (solid line) and DMPK[—/—] mice 
(dashed line). Depolarization was generated by 20 |xM ACh (A) or 125 mM KCI (B) as marked by the bars. Traces show the average [Ca2+], after 
superimposing all appropriate experiments as listed in Table I.
age-operated Na+ channels in cultured skeletal muscle cells 
(28, 32), The K+-triggered Ca2+ transients are not affected by 
tetrodotoxin (Fig. 4 C), as expected. It is important to note 
that neither of the three inhibitors have any effect on the rest­
ing [Ca2+]i (Figs. 2 A ,  3 A ,  and 4 A ).
Depolarization of the cultured muscle cells in the absence 
of extracellular Ca2* could not be performed, since the omis­
sion of external Ca2 h before depolarization provokes a Ca21 
transient (data not shown). As a result, the SR becomes at 
least partially depleted for Ca2+, which in turn can affect the 
kinetics of the SR Ca2+ release channel (33). In addition, the 
DHPR may become inactivatable due to a loss in occupancy of 
its priming site (23,25).
Ca2* homeostasis of DMPK[—/ —J skeletal muscle cells. 
Surprisingly, the resting [C&2*]i (185 nM) of DMPK[—/—] skel­
etal muscle cells in culture is significantly higher than in wild- 
type cells (Table I, Fig. 1). Ryanodine does not affect this 
elevated level (Fig. 2 A ), but nifedipine and tetrodotoxin nor­
malize the increased resting [Ca2+]j completely or partially, re­
spectively (Figs. 3 A  and 4 A). This means that DHPRs and 
TTXRs are constitutively open in resting mutant skeletal mus­
cle cells, unlike in wild-type cells. Strikingly, the amplitudes of 
the Ca2+ responses provoked by depolarization with ACh or 
KCI are reduced by about 40%, whereas t ( and xd are increased
2- and 1.6-fold, respectively (Fig, 1). We observed that ryano­
dine reduces the depolarization-induced Ca2+ responses in 
D M PK [-/-] cells by only 90% (Fig. 2, B and C), whereas 
complete blocking is achieved with nifedipine (Fig. 3, B and 
C), This observation indicates that the Ca2+ transients in these 
cells partially result from an influx of extracellular Ca2+ 
through the DHPRs. Tetrodotoxin incompletely inhibits ACh- 
evoked Ca2+ transients like in wild-type cells (Fig. 4 B). After 
inhibition of TTXR by tetrodotoxin, when the basal [Ca2+]j in 
D M PK [-/-] cells has become lowered, the KCl-generated 
Ca2+ responses are both higher and faster than in the absence 
of tetrodotoxin. The average amplitude of the Ca2+ transients 
raises ~  140% and ^ and Td are reduced 1.5- and 1.6-fold, re­
spectively, and become similar to the values in wild-type cells
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Figure 2. Effects of ryanodine on resting [Ca2+]{ (^ 4.) and depolarization-provoked Ca2+ responses (B and C) in cultured wild-type and 
DMPK[—/ —] muscle cells. Muscle cells were incubated with 10 p.M ryanodine for 30 min before depolarization (B and C). Traces show the mean 
[Ca2+]j after superimposing all relevant experiments as given in Table II. Ryanodine does not normalize the higher resting [Ca2f]j of DMPK[—/—] 
cells (.A ), and only partially inhibits depolarization-induced Ca2+ transients (B and C).
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Figure 3. Effects of nifedipine on resting [Ca2+]j (^4) and depolarization-generated Ca2+ transients (B and C) in cultured wild-type and 
D M P K [- / - ]  muscle cells. Muscle cells were incubated with 5 jxM nifedipine for 30 min before depolarization (B and C). For other details, see 
legend to Fig. 2. Nifedipine completely normalizes the higher resting [Ca2+]j of D M P K [- /~ ]  cells (A).
(compare Figs. 1 B and 4 C), Since these latter observations 
suggest a [Ca2+]r regulated fine-tuning of depolarization- 
induced Ca2* responses, we investigated whether there was 
any relation between [Ca2+]L and any of the parameters that 
describe the shape and the magnitude of the Ca2+ transients in 
both cell types. The calculations clearly demonstrate that the 
resting [Ca2+]i inversely correlates with [Ca2*]iimax (Fig* 5 A ), 
and exhibits a high correlation withij (Fig. 5 B). In addition, an 
inverse correlation exists between [Ca?+]i>max and T d (Fig. 5 C).
The statistical evaluations of the depolarization-induced 
Ca2+ transients of both wild-type and mutant skeletal muscle 
cells in the absence or presence of ion channel-specific inhibi­
tors are listed in Tables I and II, respectively, and sustain the 
described phenomena.
SR Ca2+-ATPcise and Nci^/K^-ATPasc. The here observed 
Ca2 h homeostasis of cultured DMPK[-/~] mouse muscle cells
has the same characteristics as in cultured skeletal muscle cells 
derived from DM patients (15,16). Since muscle and cultured 
muscle cells of patients have been shown to exhibit a lowered 
activity of both SR Ca2+-ATPase and Na '7K1 -ATPase due to 
a reduction of their content (20), we also examined these ATP- 
driven ion pumps in our wild-type and mutant mice. As for 
human (20), the activity and the concentration of SR Ca?+-ATP- 
ase as well as the independent, ouabain-sensitive 3-O-MFPase 
activity and the ouabain-binding capacity, i.e., the number of 
Na+/K+~ ATPase molecules, are lower in cultured mouse mus­
cle cells than in mouse whole hind limb muscle, but the molec­
ular activities do not differ (Table III). Furthermore, pairwise 
comparison between the two types of cultured muscle cells or 
skeletal muscle of wild-type and DM PK[-/—] mice do not re­
veal any difference in the activity or content of SR Ca2+- 
ATPase and Na+/K+-ATPase (Table IU).
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Figure 4. Effects of tetrodotoxin on resting [Ca2+]j (A) and depolarization-elicited Ca2+ responses (B and C) in cultured wild-type and 
D M P K [- / - ]  muscle cells. Muscle cells were preincubated with 5 jjlM  tetrodotoxin for 30 min before depolarization (B and C). For other details, 
see legend to Fig. 2. Tetrodotoxin partially normalizes the higher resting [Ca2+], of DM PK[—/ —] cells (>1).
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Figure 5. [Ca2+]r regulated fine-tun­
ing of Ca2+ responses in cultured 
wild-type (open symbols) and 
D M P K [- / - ]  skeletal muscle cells 
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resent the regression curves, and 
the dotted lines mark the 99% confi­
dence intervals.
Discussion
The focus of interest in DM research has slowly drifted from 
the behavior of the instable (CTG)n repeat to the actual func­
tion (s) of individual genes in the mutant chromosome 19q 
area. Three candidate genes for the DM locus have now been 
characterized; DMR-N9, DMPK, and DMAHP (34, 35). As 
the expanding repeat in DM actually interrupts the gene for 
DMPK, most efforts in explaining disease etiology have been 
directed towards the involvement of the product(s) of this sin­
gle gene. The results presented in this paper provide novel evi­
dence that there is a specific relationship between DMPK ac-
Table II. Effects ofE-C Coupling Inhibitors on ACh- and 
KCl-induced Ca2+ Transients in Cultured Skeletal Muscle Cells 
From Wild-type and DMPK[—/—] Mice
Inhibitor Stimulus Parameter Wild-type DM PK [ - / —]
Ryanodine (10 |x M ) ACh [^ 3  li.basnl 119 ±21 182 ±38*
[C a2+]j,max 119±21 251±31*
(40) (21)
KCI [Ca2+]ihasaj 120 ±24 179±39*
[Ca2+]iimax 120±24 248±31 *
(28) (17)
Nifedipine (5 | j lM ) ACh [C a2+lj,basal 120±23 127 ±33
[Ca2+]iiinax 120±23 127 ±3 3
(42) (19)
KCI ]t,basal 121 ± 2 0 125 ±29
[Ca2+]Lmax 121 ± 2 0 125 ±29
(52) (32)
Tetrodotoxin (5 jjlM) ACh [Ca"+k  basal 120 ±23 155±36*
[Ca2,U x 378 ±56 351±67
(29) (23)
KCI [Ca ]i,hasal 116 ±25 153 ±40*
[Ca2+]i>max 826 ±196 719±234*
(4 8 ) (45)
Values expressed in nM, are means±SD of the number of muscle cells 
(listed between parentheses) from at least three individual cultures. 
Concentrations of ACh and KCI are 20 jxM and 125 mM, respectively. 
Parameters of D M P K [-/-]  and wild-type cells differ with *P <  0.01 
and iP <  0.05. In the presence of tetrodotoxin Tj of the KCl-evoked 
Ca2‘h responses in wild-type and mutant cells are 3.1±0.9 s and 4.2±1.3 s 
(P <  0.01), whereas r d are 4.9±1.1 s and 5.5 ±1.5 s (P < 0.05), respec­
tively.
tivity and Ca2'*' homeostasis in skeletal muscle cells. Although 
results from DMPK-cDNA transfection studies in BC3H1 cells 
pointed to a function of DMPK in the myogenic pathway (36), 
we conclude from study of the close-to-natural context pre­
sented here, that the sole absence of DMPK does not appear 
to interfere with the growth and differentiation profiles of 
muscle-derived satellite cells in vitro. Neither the morphologi­
cal appearance, nor the maturation grade, or the ability to con­
tract, differed between wild-type and mutant cells. Moreover, 
our observations are in accordance with the absence of any 
gross morphological and structural modifications in vivo in 
mice that lack or overexpress the DMPK gene (9,10).
The behavior of Ca2+ homeostasis in cultured muscle cells 
depends on DMPK activity. Estimates for resting [Ca2+]j val­
ues of mouse skeletal muscle cells in culture clearly depend on 
the cell origin, the Ca2+ indicator used for assaying, and the cal­
ibration procedure applied. All we can say is that our value for 
the resting [Ca2+], in cultured muscle cells of wild-type mice, 
based on the in vivo calibration of Fura-2, falls well within the 
range of values published for cultured mouse myotubes (37) 
and myofibers in vivo (38). Since inhibition of the SR Ca2+ re­
lease channel by ryanodine effectively blocks depolarization- 
induced Ca2+ efflux in cultured wild-type cells (Fig. 2, B and C), 
these cells, like those of rats and humans, must possess a skele­
tal muscle type of E-C coupling mechanism, rather than a car­
diac muscle type, in which Ca2+ release is provoked by an influx 
of external Ca2+ (28,31), Moreover, it suggests that the contri­
bution of a Ca2+ influx through the ion-unselective AChR (39), 
the dihydropyridine-insensitive fast-activated voltage-operated 
T-type Ca2+ channel (40), and/or the slow-activated voltage- 
dependent L-type Ca2+ channel, i.e., DHPR (41), during depo­
larization is negligibly small, and/or is ineffective to induce 
Ca2+ release from the SR. This does not rule out that Ca2H‘ en­
try via the DHPR may play a role in long-lasting depolariza­
tions in wild-type cells, but usually this process is slower than 
the charge movement in DHPR and the associated activation 
of the RyR (41).
The situation in mutant myotubes is clearly different in that 
absence of DMPK augments the resting [Ca2+]j, and has damp­
ening effects on the release and sequestration of Ca2+ upon 
depolarization. Application of inhibitors showed that the phe­
nomenon of higher resting [Ca2+]i and the altered excitability 
are somehow linked to the mode of action of voltage-depen­
dent Ca2+ and Na+ channels. It is unlikely that a recently de­
scribed Ca2+-specific leak channel is involved, as the situation
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Table III. SR Ca2+-ATPase and NaV/C+ -A TPase in Muscle and Cultured Muscle Cells of Wild-type and DMPK[~/~] Mice
Muscle Cultured muscle cells
Parameters Wild-lype D M PK [-/-] Wild-type D M P K [ - / - ]
SR Ca2+-ATPase activity (mU/mg protein) 
SR Ca2+-ATPase content (pmol/mg protein) 
Molecular activity (min-1)
Na+/K +-ATPase activity (mU/mg protein) 
Na+/K +-ATPase content (pmol/mg protein) 
Molecular activity (min-1)
76.2±7.4 (5) 
94.9±8.0 (5) 
802±14 (5) 
0.57 ±0.06 (5) 
6.3 ±0.6 (5) 
91 ±7  (5)
75.9±4.5 (3) 
94.7 ±5.8 (3) 
801 ± 9  (3) 
0.56±0.08 (3) 
6.2±0.2 (3) 
89± 11(3)
13.1 ±2.3 (8) 
16.4±2.8 (8) 
800±8 (8) 
0.93±0.09 (7)
10.1 ±0.7 (5) 
92 ±8  (5)
13.3±1.8 (4) 
16.5±2.0 (4) 
803 ±13 (4) 
0.95 ±0.13 (4) 
10.4±1.6 (4) 
91 ±8  (4)
Values are means±SD of the number of muscles or muscle cell cultures (given between parentheses). The activity and content of SR Ca2+-ATPasc 
were determined by Ca2+-dependent ATP hydrolysis and steady-state phosphorylation, respectively. The K+-dependent, ouabain-sensitive hydrolysis 
of 3-O-MFP and the binding capacity of ouabain were used as a measure for the activity and content of Na^/K^-ATPase, respectively.
is completely normalized by nifedipine, which fails to inhibit 
this leak channel (42). Our mutant myotubes lack a protein ki­
nase that is closely related to the subfamilies of cAMP-depen- 
dent protein kinases and protein kinases C (2,43). Hence, it is 
most likely that the phosphorylation status of the Ca2+ and/or 
Na+ channels or any other protein that mediates the clustering 
of ion channels in the sarcolemma is modified in DMPK[— / —] 
myotubes. In turn, this may change the gating properties of 
these channels and/or influence the distribution and regulation 
of voltage-dependent SR Ca2+ release events (44). Impor­
tantly, phosphorylation of both the and p subunits of the 
DHPR is known to occur. Phosphorylation of the ai subunit 
leads to an increase of the Ca2+ current (45), and we would 
expect absence of phosphorylation to reduce this current, a 
feature that is inconsistent with the observed high [Ca2+]j in 
resting DMPK[-/—] cells. Perhaps more relevant is that re- 
combinant-DMPK can use the p~subunit as a substrate in vitro 
(46), although the precise effects of phosphorylation of this 
subunit, which regulates the a r subunit activity (47), are un­
known. Similarly interesting is that phosphorylation of the a 
subunit of the TTX-sensitive Na+ channel in cultured mouse 
and rat muscle cells by protein kinase C and in transfected oo­
cytes by DMPK leads to a reduction of the Na+ current (48, 
49). A persistent influx of Na+ as a consequence of DMPK ab­
sence may lead to mild long-lasting depolarization of the sar­
colemma, and results in a more frequent opening of the L-type 
Ca2+ channel. We cannot, however, exclude the possibility that 
DMPK-mediated phosphorylation primarily influences the 
gating by affecting the sarcolemmal and T-tubular architec­
ture, or is involved in the (in)activation of voltage-gated ion 
channels that set the resting membrane potential, like K4 and 
Cl" channels. Delayed rectifier (50), inward rectifier (51), as 
well as Ca2+-activated K+ channels (52) can be phosphorylated 
by cAMP-dependent protein kinase and/or protein kinase C in 
heart, smooth muscles, and neurons. Activation of protein ki­
nase C reduces Cl~-conductance and leads to myotonia (53). It 
is difficult to discriminate as ion channel regulation by phos­
phorylation is extremely complex (51, 54). Thus, although our 
findings do not provide direct clues for any of these channels 
being a direct target for DMPK, they illustrate a unique prop­
erty of DMPK, namely that it exerts a modulating function on 
the initial events of the E-C coupling in skeletal muscle. The 
localization of DMPK isoforms at sites of dense channel clus­
tering (55-57) is consistent with the fact that these processes 
occur at or close to the sarcolemma.
Relevance for disease etiology? Since [Ca2+]j is a crucial 
regulator of many physiological processes, elevated [Ca2+]j 
could potentially have profound consequences in vivo. Can we 
extrapolate our in vitro findings and relate abnormal Ca2H‘ ho­
meostasis to disease manifestation in DM patients? We realize 
that our knockout mouse and cell models do not provide a di­
rect answer to this question, as the effects of CTG expansion 
on DMPK expression still have not been clearly resolved. The 
mouse myotubes, however, do provide the ideal test system to 
study the normal biological significance of DMPK against a 
well-defined, constant genetic background. Earlier we dis­
cussed the apparent lack of an overt phenotype in our animal 
model (9) in terms of possible adaptation, compensation, or 
threshold effects, which in mice, with a relatively low muscle 
workload due to small body weight, often obscure the manifes­
tation of myopathic features (58). Here we study the system in 
isolation, outside the context of the entire tissue, and it is per­
haps more relevant that the elevated resting [Ca2+]j , and the 
effects on release and sequestration of Ca2+ coupled to abnor­
mal regulation of TTX-sensitive Na+ channels and voltage-oper­
ated L-type Ca2+ channels match the data obtained with myo- 
tubes derived from DM patients (15-18). There are also 
differences in that abnormal SR Ca2+-ATPase and Na+/K+- 
ATPase levels were not found in mouse DMPK[-/—] cells 
(Table III, 20). It is possible that Ca2+-dependent gene expres­
sion critical for these changes may have a differential threshold 
sensitivity in man and mouse, and almost certainly there are 
differential effects due to the completely distinct mutation type 
in the human and mouse situation. For example, for DM pa­
tients it is conceivable that large expansions of the (CTG^ repeat 
affect other genes in the immediate vicinity, like the down­
stream-located DMAHP gene which specifies a transcription 
factor implemented in ion-channel expression regulation (35,59).
Thus, although the cell model is clearly too simplistic, our 
finding of similar disturbances in Ca2+ homeostasis in muscle 
cells of both DM patients and DMPK[—/—] mice lends indi­
rect support to the contention that the DM mutation results in 
a reduction or redistribution of DMPK mRNA and protein 
isoforms, in line with the molecular explanations provided by 
others (8,60, 61), In conclusion, our study provides new insight 
in the relation between DMPK activity and Ca2+ res pons ive-
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ness in skeletal muscle. The suggestion that DMPK modulates 
the movement of gating charge and/or the activity of voltage - 
gated ion channels opens up new possibilities for studies into 
the molecular etiology of DM.
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